Advanz Pharma
LEI 549300WZSXRSISJ4VI31
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Profile
|
Advanz Pharma Corp. (formerly Concordia International Corp.) operates a healthcare business that includes the management and acquisition of legacy pharmaceutical products and acquires and develops orphan drugs both with patent life and exclusivity remaining (pre-legacy), and products that have reached full maturity but continue on a predictable revenue generation path, collectively referred to as legacy products.
|
General information
-
Organization nameAdvanz Pharma Corp. (formerly Concordia International Corp.)
-
Organization statusOperating organization
-
Address277 Lakeshore Road East, Oakville, Canada, L6J 1H9
-
Site
-
Previous organization nameConcordia International (to 28/11/2018)
News
-
New bond issue: Concordia Healthcare issued international bonds for USD 350.0m maturing in 2022 with a 9% coupon.07/10/2016
-
New bond issue: Concordia Healthcare sells USD 790.0m in 2022 bonds with a 9.5% coupon20/10/2015
-
New bond issue: Concordia Healthcare sells USD 735.0m in 2023 bonds with a 7% coupon14/04/2015
Stocks
General information
-
Organization nameAdvanz Pharma Corp. (formerly Concordia International Corp.)
-
Organization statusOperating organization
-
Address277 Lakeshore Road East, Oakville, Canada, L6J 1H9
-
Site
-
Previous organization nameConcordia International (to 28/11/2018)
Codes
-
LEI549300WZSXRSISJ4VI31
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
NACE*** ***
-
NAICS*** ***
-
CIK0001642271









